lobbying_activities: 2300271
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2300271 | 5f40b351-430d-4e25-b6cc-9b8e67ceefe1 | Q2 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 1466 | ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 2019 | second_quarter | MMM | On April 22, 2019 AACC wrote to the Government Accountability Office urging it to conduct a study on the impact of the Protecting Access to Medicare Act on patient access to laboratory services and low-volume laboratories. The GAO had released a report in November 2018, which addressed implementation issues associated with the law, but had neglected these two areas. | Government Accountability Office (GAO),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2019-07-09T13:47:05.090000-04:00 |